Université Pierre et Marie Curie Ecole doctorale ED394 : Physiologie et Physiopathologie et thérapeutique UMRS1138 Thèse de doctorat d’immunologie Présentée par : Priyanka DEVI Pour obtenir le titre de Docteur de l’université Pierre et Marie Curie Role and prognostic importance of regulatory T cells in lung cancer patients according to the presence of tertiary lymphoid structures Présentée et soutenue publiquement le 5 Octobre 2015 Devant un jury composé de : Prof. François Lemoine : Président du Jury Prof. Eric Tartour : Rapporteur Dr. Bruno Lucas : Rapporteur Dr. Christine Caux : Examinatrice Prof. François Ghiringhelli : Examinateur Prof. Catherine Sautés-Fridman : Invitée Dr. Marie-Caroline Dieu-Nosjean : Directrice de thèse 1 Acknowledgement First, I would like to thank Prof. Herve Fridman and Current director Mr. Pascal Ferre, for accepting me to the Centre de recherche de Cordeliers. I would like to thank you, Prof. Herve Fridman, for his scientific advices and valuable discussions during the lab-meetings which helped me to get insights of tumor immunology and helped this work to improve qualitatively. I thank Prof. Catherine Sautes-Fridman for giving me an opportunity to join this laboratory as PhD student through the Erasmus Mundus scholarship program. I thank her for the kindness and scientific discussions during the lab meetings. I thank her for giving me an opportunity to talk in the departmental day. Since, my first day in the lab, I am so pleased with your and Herve’s love about Indian food and culture. I thank their affection about India and I hope they will continue loving India. I thank Prof. François Lemoine for accepting to be president of the jury. I thank Prof. Eric Tartour and Dr. Bruno Lucas for reviewing the thesis manuscript. I thank Dr. Christine Caux and Prof. François Ghiringhelli for accepting to be examiners of the thesis. I would like to sincerely acknowledge Dr. Marie-Caroline Dieu-Nosjean, who accompanied me throughout this journey. I thank her, for her patience and the confidence she showed in me. Her scientific parenthood helped me to understand the tumor immunology, which was quite a foreign field for me on my arrival in lab. I thank her for giving me an opportunity to learn so many new techniques and helping me to be an independent in performing the experiments and understanding the results. I cannot forget the long meetings with the designing experiments or discussing the results (especially writings on the white board!). This thesis could not have been better without her motivation and immense knowledge which widen my research from various aspects. My sincere thanks also go to Dr. Jean-Luc Teillaud and Prof. Isabelle Cremer, who integrated me in this laboratory and allowed me to access the laboratory and research facilities. I also thank them for the kind follow up my work during these four years and their scientific contributions which helped this work to improve. I especially 2 thank Jean-Luc for sharing not only scientific interests, but also the political, geographic, historic and artistic views with me. I would like to thank Dr. Sophie Siberil for her contributions in the lab meeting and her kindness. I thank Dr. Audrey Lupo, Dr. Diane Damotte, Dr. Marco Alifano and the team of clinicians and pathologists at Hotel Dieu and Cochin Hospital; also to the Dr. Pierre Validire and the team at the Institute Mutualiste Montsouris hospital for their valuable help for the surgical specimen and the clinic-pathological datas of the cancer patients. Without their help this project could not have been moved ahead. I would like to thank CICC team for their grand technical support. My thanks goes to Hélène and Estelle for their great help for the flow cytometry and I thank Christophe for his help in the imaging. I wish Estelle a very good luck for end of her thesis. I thank my dear friends (“100% women’s team Marie Caroline”) i.e. Claire, Samantha, Helene, Claudia and Myriam for their love and support throughout this thesis. I would like to thank a lot of my dear post-doc Claire, for her incredible help during the experiments and her kindness. Thanks for sharing the Calopix pain with me in all these years! Your hard work and perfectionism have always been inspiring for me! I would like thank Sam for her kindness and motherhood during the molecular biology experiments. Thank you for motivating me with your kind words “ca vas aller” during stressful times! I would like to thank my dear friend Helene for her happy and humorous nature. Thank you for making me laughs all the time! I wish you a very good luck for your thesis. I would like to thank you Claudia, my English speaking companion in the team for your help and support. Thank you for teaching me the Ingenuity software and it was nice to discuss with you a lot about gene expression data. Gracias mi amiga peruana! I would like to thank Myriam for her help in the last few months of my thesis and I hope you will continue liking the Indian food. I would like to thank my former DC-Lamp companion, “Mr. DOC GOC” for his help and support during the initial phase of my thesis. I hope he will be successful in his adventures in New-York. I would also like to thank other post-docs Sarah, Jerome, Pauline in the lab. Your presence in the lab was helpful for me! I thank you Sarah for introducing the nanostring technology and most importantly for giving pleasure to hear some American 3 English in the lab! I thank you Jerome for always helping me with antibodies and also thank you for your curiosity with the Tregs project. I thank you Pauline for your kindness and help. I wish a good luck to new postdocs Mihaela and Angella for their projects in the lab. I would like to thank the IHC “super girls” Ben Ben, Tick Tick, Laetitia, Hanane, Estephania and Marion, for their “super energy” to organize parties and fun times. I thank them for keeping the IHC lab always in a full energized mode. I thank you a tennis girl Tessa for your kindness and your help in the molecular biology experiments. Thanks for sharing and teaching me how to break correctly the “Noix”! I hope you will visit the Himalayas (Mt. Everst) and of course me:P one day! I also thank the Lucie, Nathalie Josseaume, Tania, Kris and Melanie for their help. I would like to thank Gabriela and Bernhard for their advice during the bioinformatics data analyses. I would like to thank my dear Indian friend Saradiya for accompanying me in the initial years of the thesis. I was always lucky, to have you before and later Shambhu, to share Indian food and to speak in Hindi while learning French! I wish you very good luck Shambhu, to end of your thesis! Also, I would like to thank other PhD students in the lab who were sailing in the same boat with me! I would like to thank Nicolas, Etienne, Nicolas Merle, Claire Deligne, Mikael, and Benoit for their friendship throughout my thesis. I would like to thank Dr.Lubka Roumenina, Dr. Véronique Fremeaux-Bacchi and Marie-Agnes Dragon-Durey for their scientific discussions in lab meetings. I would like to thank the past and present M2 students in lab for keeping the lab young and fresh! Thanks to the past members of the lab Jeremy Cosette, Romain Remark, Caroline, Claire Galand and Duy for their help. Je vous remercie de Nathalie et Eliane pour être mère à nous tous! La manière vous soignez pour moi a toujours été incroyable! Je remercie Johanna et Lamia pour toute l'aide administrative que vous avez fait pendant toutes ces années! Je remercie Jasmina pour amener l'humour pendant le déjeuner et en général aussi! Sans vous tout le laboratoire ne peut pas fonctionner sans problèmes ! I would like to thank our collaborators in this project Sadrine Katsahian and Sylvain Leveugle from team 22 CRC for their help in the statistical analyses. I thank 4 David Gentien and Benoit Albaud for their hospitality at the Curie institute. I also thank Emmanuel Donadieu and Houcine Bougherara for their help and hospitality in Cochin institute. I would like to thank my professor Dr. Kanchanganga Gandhe for her enormous support and love during all this phase of my work. Her kind words have always motivated me all these years. I thank my dearest friend Rhucha for her incredible love and support. I would like to thank my friends in India Tejashree, Revatee, Sharvari, Kalyani, Mihir for their priceless love, friendship and their continuous support, although we were far from each other in all these thesis years. I would like to thank my parents, parent’s in-laws and my younger brother for their precious love, their kindness and their continuous support throughout this phase of my life. Words feel shorter to thank them! Last but not least, I thank deep from my heart to love of my life, my husband, Swanand who made this journey pleasant for me. I was lucky to have you with me in this beautiful and romantic city, Paris. There comes a time in PhD when you have to constantly remind yourself that not everyone is running the same race, and that you're only competing with who you were yesterday. In all those times, I thank you for being with me, for showering your relentless love and tremendous support. 5 “Life is not easy for any of us. But what of that? We must have perseverance and above all confidence in ourselves. We must believe that we are gifted for something and that this thing, at whatever cost, must be attained” -Marie Curie 6 To my parents, For their relentless love for me… 7 Table of contents Acknowledgement ................................................................................................... 2 Index of figures ...................................................................................................... 11 Index of tables ........................................................................................................ 12 Abstract 13 Abbreviations ......................................................................................................... 14 A. Introduction .................................................................................................... 17 1. Immune system and tumors: a complex discourse ....................................... 17 1.1. Origin of the concept of tumor microenvironment....................................... 17 1.2. Origin and concept of immune surveillance ................................................. 19 1.2.1. Immunoediting: 3 `E’ concept ...................................................................... 20 1.3. Tumor microenvironment: a complex interactome ...................................... 22 1.3.1. Characteristics of contexture ........................................................................ 24 1.3.2. Cancer associated TLS ................................................................................. 25 1.3.2.1. General characteristics of TLS ........................................................ 25 1.3.2.2. Formation of TLS ............................................................................ 26 1.3.3. TLS in anti-tumor immune response ............................................................ 28 1.4. Infiltration of immune cells in solid tumor: a strong prognostic marker ..... 31 1.4.1. Prognostic importance of the TLS in cancer ...................................... 32 2. Tregs: Key Regulators of anti-tumor immune response............................... 35 2.1. Discovery and features of regulatory T cells ................................................ 35 2.2. Regulatory T cell subsets.............................................................................. 38 2.3. Regulatory mechanisms exerted by Tregs .................................................... 41 2.3.1. Inhibitory cytokines ...................................................................................... 42 2.3.2. Suppression by cytolysis .............................................................................. 43 2.3.3. Suppression by metabolic disruption............................................................ 44 8 2.3.4. Cell to cell contact dependent suppression: Involvement of co-stimulatory and co-inhibitory signals............................................................................................... 45 2.4. How many mechanisms do Tregs need? Treg plasticity .............................. 51 2.5. Infiltration, differentiation and activation of Tregs in tumor microenvironment 53 2.5.1. Infiltration of Tregs in tumor microenvironment ......................................... 53 2.5.2. Expansion and activation of Tregs ............................................................... 55 2.5.3. Antigen specificity of Tregs in cancer .......................................................... 55 2.6. Tregs in cancer: ambiguity in prognostic importance .................................. 56 3. Tregs and immunotherapy: a blessing in disguise? ...................................... 60 4. Lung cancer: a study model .......................................................................... 66 4.1. Etiology and histology of the lung cancer .................................................... 67 4.2. TNM classification and survival of patients ................................................. 68 4.3. Treatment of lung cancer patients ................................................................ 71 4.4. Era of combined therapies: promising for NSCLC ...................................... 72 B. Hypothesis and objectives .............................................................................. 75 C. Results 80 References 106 Tregs in advanced stage chemotherapy treated lung cancer patients .................. 141 D. Discussion ..................................................................................................... 146 TLS in lung tumors: centers of the protective immune responses ....................... 146 Infiltration, activation of Tregs in cancer microenvironment .............................. 147 Anti-inflammatory role of Tregs in lung cancer .................................................. 150 Tregs in TLS: Proponents or opponents?............................................................. 152 Expansion of the specific subsets of Tregs in TLS .............................................. 156 Modulation of the Treg phenotype in the neoadjuvant chemotherapy treated lung cancer ................................................................................................................... 157 Prognostic outcome of Tregs in lung cancer patients .......................................... 158 9 E. Limitations of this study ............................................................................... 161 F. Conclusion and perspectives ........................................................................ 162 G. References .................................................................................................... 165 Publication bibliography ...................................................................................... 165 H. Annex 199 10
Description: